DrugPatentWatch Database Preview

Chartwell Molecules Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?

CHARTWELL MOLECULES has twenty approved drugs.

Summary for Chartwell Molecules

US Patents:	0
Tradenames:	15
Ingredients:	15
NDAs:	20

Drugs and US Patents for Chartwell Molecules

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecules	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	077303-002	Jun 25, 2007		DISCN	No	No
Chartwell Molecules	ACYCLOVIR	acyclovir	TABLET;ORAL	074834-001	Apr 24, 1997		DISCN	No	No
Chartwell Molecules	SELEGILINE HYDROCHLORIDE	selegiline hydrochloride	TABLET;ORAL	074565-001	Aug 2, 1996		DISCN	No	No
Chartwell Molecules	CLONIDINE HYDROCHLORIDE	clonidine hydrochloride	TABLET;ORAL	071785-003	Apr 5, 1988		DISCN	No	No
Chartwell Molecules	ETODOLAC	etodolac	CAPSULE;ORAL	074842-001	Jul 17, 1997		DISCN	No	No
Chartwell Molecules	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	TABLET;ORAL	074093-002	Nov 5, 1992		DISCN	No	No
Chartwell Molecules	CIMETIDINE	cimetidine	TABLET;ORAL	074329-001	May 17, 1994		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chart Medcl
• Chartwell Life Sci
• Chartwell Molecular
• Chartwell Molecules
• Chartwell Pharma
• Chartwell Rx
• Chartwell Tetra